News

Research in preclinical models suggests that recombinant molecule could act as a topical anti-HIV microbicide.

Low oxygen levels are a well-known cause of brain injury in premature babies. Until now, the mechanism by which low oxygen hurts the developing human brain has been unclear.

Researchers at the Koch Institute for Integrative Cancer Research at MIT describe a new approach to targeting tumors and metastases.

If your childhood involved countless hours spent capturing, training and battling Pokémon, there may be a wrinkle in your brain that is fond of images of Wobbuffet, Bulbasaur and Pikachu. The findings, published online in the journal Nature Human Behavior, help shed light on two related mysteries about our visual system.

A new immunodeficiency disease caused by a novel genetic mutation has been identified by researchers.

Like finding a needle in a haystack, identifying genes that are involved in particular diseases can be an arduous and time consuming process. Looking to improve this process, researchers have developed a new bioinformatics tool that analyzes CRISPR pooled screen data and identifies candidates for potentially relevant genes with greater sensitivity and accuracy than other existing methods.

A type of skin-related stem cell could be used to help regenerate myelin sheaths, a vital part of the nervous system linked to neurodegenerative disorders.

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients.

People have certain physical 'tells' when they conceal information - and studies show that good liars can prevent these 'tells' being detected by displaying physical red herrings of their own. But scientists have now shown that even a brain imaging technique called fMRI, which in theory is much harder to trick, can be beaten by people who use two particular mental countermeasures.

Scientists have identified a gene mutation in the tumors of men with prostate cancer that is linked to very poor survival – and which could be used to pick out patients for especially intensive treatment.